GDF15 and primary biliary cholangitis: The ROC curve comparing biochemical responders and non-responders in cirrhotic PBC patients suggested that GDF15 levels could be used to differentiate biochemical non-responders to UDCA treatment among cirrhotic PBC patients with an AUROC of 0.835.